Dr. Desiree E. Doncals
Claim this profileSumma Health System - Akron Campus
Area of expertise
Breast Cancer
Desiree E. Doncals has run 2 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Desiree E. Doncals has run 2 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Summa Health System - Akron Campus
Summa Health System - Barberton Campus
Clinical Trials Desiree E. Doncals is currently running
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting
2 awards
Phase 3
13 criteria
Hormone Therapy + Radiation
for Prostate Cancer
This phase III trial uses the Decipher risk score to guide therapy selection. Decipher score is based on the activity of 22 genes in prostate tumor and may predict how likely it is for recurrent prostate cancer to spread (metastasize) to other parts of the body. Decipher score in this study is used for patient selection and the two variations of treatment to be studied: intensification for higher Decipher score or de-intensification for low Decipher score. Patients with higher Decipher risk score will be assigned to the part of the study that compares the use of 6 months of the usual treatment (hormone therapy and radiation treatment) to the use of darolutamide plus the usual treatment (intensification). The purpose of this section of the study is to determine whether the additional drug can reduce the chance of cancer coming back and spreading in patients with higher Decipher score. The addition of darolutamide to the usual treatment may better control the cancer and prevent it from spreading. Alternatively, patients with low Decipher risk score will be assigned to the part of the study that compares the use of radiation treatment alone (de-intensification) to the usual approach (6 months of hormone therapy plus radiation). The purpose of this part of the study is to determine if radiation treatment alone is as effective compared to the usual treatment without affecting the chance of tumor coming back in patients with low Decipher score prostate cancer. Radiation therapy uses high energy to kill tumor cells and reduce the tumor size. Hormone therapy drugs such as darolutamide suppress or block the production or action of male hormones that play role in prostate cancer development. Effect of radiation treatment alone in patients with low Decipher score prostate cancer could be the same as the usual approach in stabilizing prostate cancer and preventing it from spreading, while avoiding the side effects associated with hormonal therapy.
Recruiting
2 awards
Phase 3
1 criteria
More about Desiree E. Doncals
Clinical Trial Related
10 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Desiree E. Doncals has experience with
- Degarelix
- Radiation Therapy
- Triptorelin
- Leuprolide
- Histrelin
- Buserelin
Breakdown of trials Desiree E. Doncals has run
Breast Cancer
Lung Cancer
Prostate Adenocarcinoma
Breast cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Desiree E. Doncals specialize in?
Desiree E. Doncals focuses on Breast Cancer and Lung Cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are HER2 positive.
Is Desiree E. Doncals currently recruiting for clinical trials?
Yes, Desiree E. Doncals is currently recruiting for 2 clinical trials in Akron Ohio. If you're interested in participating, you should apply.
Are there any treatments that Desiree E. Doncals has studied deeply?
Yes, Desiree E. Doncals has studied treatments such as Degarelix, Radiation Therapy, Triptorelin.
What is the best way to schedule an appointment with Desiree E. Doncals?
Apply for one of the trials that Desiree E. Doncals is conducting.
What is the office address of Desiree E. Doncals?
The office of Desiree E. Doncals is located at: Summa Health System - Akron Campus, Akron, Ohio 44304 United States. This is the address for their practice at the Summa Health System - Akron Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.